Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2025-12-25 @ 1:14 PM
NCT ID:
NCT04836559
Pre Assignment Details:
PK sets: randomized participants who received at least (\>=)1 dose of JNJ-40411813 and had \>=1 valid blood sample drawn for PK analysis and excluded samples with below lower limit of quantification or with inconsistent date/time or with previous dose date/time incomplete or samples with concentration \<10 nanograms per milliliter. Safety set: randomized participants who received \>=1 dose of JNJ-40411813/placebo. Due to inclusion/exclusion criteria difference, PK set count differed from safety set.
Recruitment Details:
Participants with diagnosis of focal onset seizures and receiving levetiracetam or brivaracetam and up to 3 other anti-epileptic drugs (AEDs) were enrolled in study. Study consisted of cohort 1 and 2. In each cohort, participants were stratified into two groups: participants treated with a CYP3A4 enzyme inducing anti-epileptic drugs (EIAED \[induced participants\]) and those not treated with a CYP3A4 EIAED (non-induced participants).
Study:
NCT04836559
Study Brief:
Results Section:
NCT04836559